Keratoacanthoma Pathobiology in Mouse Models

Katherine N Gibson-Corley; Laura M Rogers; Adam Goeken; Adam J Dupuy; David K Meyerholz

doi:10.3390/diseases2020106

Back

Keratoacanthoma Pathobiology in Mouse Models

Journal article

Open access

Peer reviewed

Keratoacanthoma Pathobiology in Mouse Models

Katherine N Gibson-Corley, Laura M Rogers, Adam Goeken, Adam J Dupuy and David K Meyerholz

Diseases, Vol.2(2), pp.106-119

05/23/2014

DOI: 10.3390/diseases2020106

PMCID: PMC4190131

PMID: 25309748

Files and links (1)

url

https://doi.org/10.3390/diseases2020106View

Published (Version of record) Open Access

Abstract

Recently we described skin tumors driven by skin-specific expression of Zmiz1 and here we define keratoacanthoma pathobiology in this mouse model. Similar to human keratoacanthoma development, we were able to segregate murine keratoacanthomas into three developmental phases: growth, maturation, and regression. These tumors had areas with cellular atypia, high mitotic rate, and minor local invasion in the growth phase, but with development they transitioned to maturation and regression phases with evidence of resolution. The early aggressive appearance could easily be misdiagnosed as a malignant change if the natural pathobiology was not well-defined in the model. To corroborate these findings in the Zmiz1 model, we examined squamous skin tumors from another tumor study in aging mice, and these tumors followed a similar biological progression. Lastly, we were able to evaluate the utility of the model to assess immune cell infiltration (F4/80, B220 Granzyme B, CD3 cells, arginase-1) in the regression phase; however, because inflammation was present at all phases of development, a more comprehensive approach will be needed in future investigations. Our study of keratoacanthomas in selected murine models suggests that these squamous tumors can appear histologically aggressive during early development, but with time will enter a regression phase indicating a benign biology. Importantly, studies of squamous skin tumor models should be cautious in tumor diagnosis as the early growth distinction between malignant versus benign based solely on histopathology may not be easily discerned without longitudinal studies to confirm the tumor pathobiology.

mouse models

histopathology

keratoacanthoma

regression

Details

Title: Subtitle: Keratoacanthoma Pathobiology in Mouse Models
Creators: Katherine N Gibson-Corley - Department of Pathology, University of Iowa, Iowa City, IA 52242, USA
Laura M Rogers - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA
Adam Goeken - Department of Pathology, University of Iowa, Iowa City, IA 52242, USA
Adam J Dupuy - Department of Anatomy & Cell Biology, Roy J. & Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
David K Meyerholz - Department of Pathology, University of Iowa, Iowa City, IA 52242, USA
Resource Type: Journal article
Publication Details: Diseases, Vol.2(2), pp.106-119
DOI: 10.3390/diseases2020106
PMID: 25309748
PMCID: PMC4190131
NLM abbreviation: Diseases
ISSN: 2079-9721
eISSN: 2079-9721
Language: English
Date published: 05/23/2014
Academic Unit: Anatomy and Cell Biology; Pathology; Holden Comprehensive Cancer Center; Ophthalmology and Visual Sciences
Record Identifier: 9984025460802771

Metrics

97 Record Views